Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 11
127
mi
from 43215
Cleveland, OH
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 11
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site
1
mi
from 43215
Columbus, OH
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site
1
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site
849
mi
from 43215
Oklahoma City, OK
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10183
416
mi
from 43215
Philadelphia, PA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10183
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 12467
525
mi
from 43215
Mount Pleasant, SC
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 12467
525
mi
from 43215
Mount Pleasant, SC
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 13560
237
mi
from 43215
Bristol, TN
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 13560
237
mi
from 43215
Bristol, TN
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 084
508
mi
from 43215
Memphis, TN
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 084
508
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 1310
332
mi
from 43215
Nashville, TN
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 1310
332
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10372
mi
from 43215
Arlington, TX
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10372
mi
from 43215
Arlington, TX
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10405
mi
from 43215
Austin, TX
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10405
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 12222
278
mi
from 43215
Charlottesville, VA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 12222
278
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 1339
249
mi
from 43215
Roanoke, VA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 1339
249
mi
from 43215
Roanoke, VA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 1327
1651
mi
from 43215
Gilbert, AZ
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 1327
1651
mi
from 43215
Gilbert, AZ
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 043
1653
mi
from 43215
Scottsdale, AZ
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 043
1653
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site
624
mi
from 43215
Little Rock, AR
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site
624
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10802
mi
from 43215
Phoenix, AR
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10802
mi
from 43215
Phoenix, AR
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10358
1960
mi
from 43215
Anaheim, CA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10358
1960
mi
from 43215
Anaheim, CA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 1326
1960
mi
from 43215
Fullerton, CA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 1326
1960
mi
from 43215
Fullerton, CA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10147
1977
mi
from 43215
Long Beach, CA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10147
1977
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10665
1949
mi
from 43215
Oceanside, CA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10665
1949
mi
from 43215
Oceanside, CA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 69
2107
mi
from 43215
San Francisco, CA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 69
2107
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 4
2101
mi
from 43215
Stanford, CA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 4
2101
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10129
2086
mi
from 43215
Walnut Creek, CA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10129
2086
mi
from 43215
Walnut Creek, CA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 1344
1174
mi
from 43215
Boulder, CO
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 1344
1174
mi
from 43215
Boulder, CO
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 13071
503
mi
from 43215
Stamford, CT
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 13071
503
mi
from 43215
Stamford, CT
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10369
mi
from 43215
DeLand, FL
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10369
mi
from 43215
DeLand, FL
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 11141
989
mi
from 43215
Hialeah, FL
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 11141
989
mi
from 43215
Hialeah, FL
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 12535
978
mi
from 43215
Hollywood, FL
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 12535
978
mi
from 43215
Hollywood, FL
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 021
670
mi
from 43215
Jacksonville, FL
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 021
670
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10715
788
mi
from 43215
Maitland, FL
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10715
788
mi
from 43215
Maitland, FL
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10269
795
mi
from 43215
Orlando, FL
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10269
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10064
746
mi
from 43215
Ormond Beach, FL
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10064
746
mi
from 43215
Ormond Beach, FL
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 140
756
mi
from 43215
Port Orange, FL
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 140
756
mi
from 43215
Port Orange, FL
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10593
997
mi
from 43215
South Miami, FL
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10593
997
mi
from 43215
South Miami, FL
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 096
436
mi
from 43215
Atlanta, GA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 096
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 01
433
mi
from 43215
Decatur, GA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 01
433
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 13535
439
mi
from 43215
Douglasville, GA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 13535
439
mi
from 43215
Douglasville, GA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10380
mi
from 43215
Evansville, IN
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10380
mi
from 43215
Evansville, IN
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 1334
628
mi
from 43215
Lenexa, KA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 1334
628
mi
from 43215
Lenexa, KA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10538
642
mi
from 43215
Brockton, MA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10538
642
mi
from 43215
Brockton, MA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site CHACHAR
642
mi
from 43215
New Bedford, MA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site CHACHAR
642
mi
from 43215
New Bedford, MA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 51
563
mi
from 43215
Springfield, MA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 51
563
mi
from 43215
Springfield, MA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 603
mi
from 43215
Watertown, MA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 603
mi
from 43215
Watertown, MA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 115
604
mi
from 43215
Worcester, MA
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 115
604
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 098
164
mi
from 43215
Ann Arbor, MI
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 098
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 114
208
mi
from 43215
Kalamazoo, MI
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 114
208
mi
from 43215
Kalamazoo, MI
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 39
630
mi
from 43215
Golden Valley, MN
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 39
630
mi
from 43215
Golden Valley, MN
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 13534
618
mi
from 43215
Kansas City, MO
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 13534
618
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10552
394
mi
from 43215
Saint Louis, MO
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10552
394
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 13536
585
mi
from 43215
Springfield, MO
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 13536
585
mi
from 43215
Springfield, MO
Click here to add this to my saved trials